share_log
Moomoo 24/7 ·  Apr 23 07:00
Theriva™ Biologics Announces Positive Topline Data From Investigator Sponsored Phase 1 Trial of Intravitreal Vcn-01 in Pediatric Patients With Refractory Retinoblastoma
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment